申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
公开号:EP0055917A1
公开(公告)日:1982-07-14
Benzothiazine compounds having the general formula:-
wherein R1 is lower alkyl opt. substituted by carboxy, aryl and carboxy(lower)cycloalkyl; aryl opt. substituted by halogen, lower alkyl, halo(lower)alkyl and lower alkoxy; haloarylamino; or heterocyclic group;
R2 is hydrogen, lower alkyl, lower alkylamino(lower)alkyl, aryl or ar(lower)aikyl;
and R3 is hydrogen, halogen, lower alkyl or lower alkoxy;
n is 0, 1 or 2
and their pharmaceutically acceptable salts are useful in the treatment of autoimmune diseases.
通式为:- 的苯并噻嗪化合物
其中 R1 选为被羧基、芳基和羧基(低级)环烷基取代的低级烷基; 选为被卤素、低级烷基、卤代(低级)烷基和低级烷氧基取代的芳基; 卤代芳基氨基;或杂环基团;
R2 是氢、低级烷基、低级烷基氨基(低级)烷基、芳基或芳基(低级);
R3 是氢、卤素、低级烷基或低级烷氧基;
n 是 0、1 或 2
及其药学上可接受的盐类可用于治疗自身免疫性疾病。